Biomarkers, Clinical Variables, and the CHA2DS2-VASc Score to Detect Silent Brain Infarcts in Atrial Fibrillation Patients

Overview

Journal J Stroke

Date 2021 Oct 15

PMID 34649390

Citations 2

Authors

Philipp Krisai

Ceylan Eken

Stefanie Aeschbacher

Michael Coslovsky

Vinzent Rolny

Desiree Carmine

Lorenzo Grazioli Gauthier

Jurg Beer

Laurent Roten

Oliver Baretella

Nicolas Rodondi

Leo H Bonati

Christine S Zuern

Christian Muller

David Conen

Michael Kuhne

Stefan Osswald

Affiliations

Soon will be listed here.

Citing Articles

Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation.

De Marchis G, Krisai P, Werlen L, Sinnecker T, Aeschbacher S, Dittrich T Stroke. 2023; 54(10):2542-2551.

PMID: 37548011 PMC: 10519288. DOI: 10.1161/STROKEAHA.123.043302.

Bone Morphogenetic Protein 10-A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation.

Hennings E, Blum S, Aeschbacher S, Coslovsky M, Knecht S, Eken C J Am Heart Assoc. 2023; 12(6):e028255.

PMID: 36926939 PMC: 10111531. DOI: 10.1161/JAHA.122.028255.

References

Wunderlich M, Hanhoff T, Goertler M, Spener F, Glatz J, Wallesch C . Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke. J Neurol. 2005; 252(6):718-24. DOI: 10.1007/s00415-005-0725-z. View

Van Gelder I, Healey J, Crijns H, Wang J, Hohnloser S, Gold M . Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J. 2017; 38(17):1339-1344. DOI: 10.1093/eurheartj/ehx042. View

Conen D, Rodondi N, Muller A, Beer J, Ammann P, Moschovitis G . Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2019; 73(9):989-999. DOI: 10.1016/j.jacc.2018.12.039. View

Conway D, Buggins P, Hughes E, Lip G . Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol. 2004; 43(11):2075-82. DOI: 10.1016/j.jacc.2003.11.062. View

Sharma A, Hijazi Z, Andersson U, Al-Khatib S, Lopes R, Alexander J . Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation. Circulation. 2018; 138(16):1666-1676. DOI: 10.1161/CIRCULATIONAHA.118.034125. View

Feigin V, Roth G, Naghavi M, Parmar P, Krishnamurthi R, Chugh S . Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol. 2016; 15(9):913-924. DOI: 10.1016/S1474-4422(16)30073-4. View

Beck H, Acker T, Wiessner C, Allegrini P, Plate K . Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat. Am J Pathol. 2000; 157(5):1473-83. PMC: 1885747. DOI: 10.1016/S0002-9440(10)64786-4. View

Nasreddine Z, Phillips N, Bedirian V, Charbonneau S, Whitehead V, Collin I . The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53(4):695-9. DOI: 10.1111/j.1532-5415.2005.53221.x. View

Hohnloser S, Hijazi Z, Thomas L, Alexander J, Amerena J, Hanna M . Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J. 2012; 33(22):2821-30. DOI: 10.1093/eurheartj/ehs274. View

10.

Januzzi Jr J, Packer M, Claggett B, Liu J, Shah A, Zile M . IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure. Circ Heart Fail. 2018; 11(10):e005133. DOI: 10.1161/CIRCHEARTFAILURE.118.005133. View

11.

Ellison J, Velier J, Spera P, Jonak Z, Wang X, Barone F . Osteopontin and its integrin receptor alpha(v)beta3 are upregulated during formation of the glial scar after focal stroke. Stroke. 1998; 29(8):1698-706; discussion 1707. DOI: 10.1161/01.str.29.8.1698. View

12.

Lip G, Patel J, Hughes E, Hart R . High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke. 2007; 38(4):1229-37. DOI: 10.1161/01.STR.0000260090.90508.3e. View

13.

Hijazi Z, Lindback J, Alexander J, Hanna M, Held C, Hylek E . The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation. Eur Heart J. 2016; 37(20):1582-90. PMC: 4875560. DOI: 10.1093/eurheartj/ehw054. View

14.

Rocha S, Schiller M, Jing D, Li H, Butz S, Vestweber D . Esm1 modulates endothelial tip cell behavior and vascular permeability by enhancing VEGF bioavailability. Circ Res. 2014; 115(6):581-90. DOI: 10.1161/CIRCRESAHA.115.304718. View